Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.

Journal article

OBJECTIVE: Despite the clinical importance of an accurate diagnosis in individuals with monogenic forms of diabetes, restricted access to genetic testing leaves many patients with undiagnosed diabetes. Recently, common variation near the HNF1 homeobox A (HNF1A) gene was shown to influence C-reactive protein levels in healthy adults. We hypothesized that serum levels of high-sensitivity C-reactive protein (hs-CRP) could represent a clinically useful biomarker for the identification of HNF1A mutations causing maturity-onset diabetes of the young (MODY). RESEARCH DESIGN AND METHODS: Serum hs-CRP was measured in subjects with HNF1A-MODY (n = 31), autoimmune diabetes (n = 316), type 2 diabetes (n = 240), and glucokinase (GCK) MODY (n = 24) and in nondiabetic individuals (n = 198). The discriminative accuracy of hs-CRP was evaluated through receiver operating characteristic (ROC) curve analysis, and performance was compared with standard diagnostic criteria. Our primary analyses excluded approximately 11% of subjects in whom the single available hs-CRP measurement was >10 mg/l. RESULTS: Geometric mean (SD range) hs-CRP levels were significantly lower (P

Authors: Owen, K; Thanabalasingham, G; James, T; Karpe, F; Farmer, A

• Publication status: Published
• Journal: Diabetes care
• Volume: 33
• Issue: 9
• Pages: 1919-1924
• Publication date: 2010-09-01
• DOI: 10.2337/dc10-0288
• EISSN: 1935-5548
• ISSN: 0149-5992
• Language: English
• Keywords: Adolescent; Mutation; Humans; Young Adult; Adult; Glucokinase; Female; Diabetes Mellitus, Type 2; Biological Markers; C-Reactive Protein; Hepatocyte Nuclear Factor 1-alpha; Male